954230-39-8 Usage
General Description
3-(4-Fluoro-phenyl)-5-methyl-isoxazole-4-carboxylic acid ethyl ester is a chemical compound with the molecular formula C12H11NO3F. It is a derivative of isoxazole and carboxylic acid, with a phenyl group containing a fluorine atom and a methyl group attached to the isoxazole ring. 3-(4-FLUORO-PHENYL)-5-METHYL-ISOXAZOLE-4-CARBOXYLIC ACID ETHYL ESTER is commonly used in pharmaceutical research and drug development due to its potential biological activity. Ethyl ester group makes the compound more lipophilic and easier to administer in pharmaceutical formulations. It has the potential to exhibit various pharmacological properties, including antimicrobial, anti-inflammatory, and analgesic effects. Further research and testing are necessary to fully understand the properties and potential applications of this chemical compound.
Check Digit Verification of cas no
The CAS Registry Mumber 954230-39-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,4,2,3 and 0 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 954230-39:
(8*9)+(7*5)+(6*4)+(5*2)+(4*3)+(3*0)+(2*3)+(1*9)=168
168 % 10 = 8
So 954230-39-8 is a valid CAS Registry Number.
InChI:InChI=1/C13H12FNO3/c1-3-17-13(16)11-8(2)18-15-12(11)9-4-6-10(14)7-5-9/h4-7H,3H2,1-2H3
954230-39-8Relevant articles and documents
Design, docking and synthesis of novel bromo isatin incorporated isoxazole derivatives as vegfr-2 inhibitors
Radhika,Saisree,Harinadha, Babu V.
, p. 1 - 7 (2019/05/17)
Objective: To design, synthesize, in vitro Vascular Endothelial Growth Factor Receptor (VEGFR-2) assay, antiproliferative activity an Absorption, Distribution, Metabolism, Excretion and Toxicity (ADMET) studies of some novel bromoisatin incorporated isoxa
SOLID FORMS OF 1,L-DIOXO-4-THIOMORPHOLINYL)-[6-[[3(4-FLUOROPHENYL)-5-METHYL-4-ISOXAZOLYL]METHOXY]-3-PYRIDINYL]-METHANONE
-
Page/Page column 36, (2013/05/09)
The instant invention relates to novel solid forms of the compound of formula (I), as well as solvates, inclusion complexes with other suitable compounds, processes for their manufacture, pharmaceutical compositions containing these solid forms, and their
PROCESS FOR THE PREPARATION OF ISOXAZOLYL- METHOXY NICOTINIC ACIDS
-
Paragraph 0220, (2013/05/08)
The present invention relates to a process for the preparation of a compound of formula (I) wherein R1 and R2 are as defined herein, which is useful as an intermediate in the preparation of active pharmaceutical compounds.
